Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
33,869,172
-
Share change
-
-838,353
-
Total reported value
-
$443,992,925
-
Put/Call ratio
-
1.6%
-
Price per share
-
$13.11
-
Number of holders
-
112
-
Value change
-
-$9,642,079
-
Number of buys
-
62
-
Number of sells
-
38
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q2 2023
As of 30 Jun 2023,
Pulmonx Corp - COM (LUNG) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,869,172 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Point72 Asset Management, L.P., BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BRAIDWELL LP, KPCB XIII Associates, LLC, and STATE STREET CORP.
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.